H. Zeitler

967 total citations
22 papers, 736 citations indexed

About

H. Zeitler is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, H. Zeitler has authored 22 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Hematology and 5 papers in Genetics. Recurrent topics in H. Zeitler's work include Platelet Disorders and Treatments (9 papers), Hemophilia Treatment and Research (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). H. Zeitler is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Hemophilia Treatment and Research (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). H. Zeitler collaborates with scholars based in Germany, Russia and Austria. H. Zeitler's co-authors include G Ulrich‐Merzenich, H. Vetter, Hildebert Wagner, Darius Panek, Johannes Oldenburg, A. Pavlova, Georg Goldmann, S. Thierfelder, C. Frisch and Christian G. Bien and has published in prestigious journals such as Phytomedicine, Planta Medica and Haemophilia.

In The Last Decade

H. Zeitler

22 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Zeitler Germany 14 217 216 91 90 79 22 736
Yu Guan China 13 124 0.6× 346 1.6× 134 1.5× 89 1.0× 3 0.0× 28 796
Masayoshi Kibata Japan 17 41 0.2× 301 1.4× 62 0.7× 11 0.1× 27 0.3× 44 928
Valeriu Atanasiu Romania 10 74 0.3× 128 0.6× 35 0.4× 42 0.5× 6 0.1× 20 396
Darius Panek Germany 10 31 0.1× 201 0.9× 84 0.9× 20 0.2× 10 0.1× 10 477
Hans Dierck Waller Germany 11 66 0.3× 188 0.9× 56 0.6× 60 0.7× 8 0.1× 14 609
Hasan Veysi Güneş Türkiye 15 42 0.2× 199 0.9× 64 0.7× 15 0.2× 7 0.1× 49 660
Yifang Li China 13 19 0.1× 207 1.0× 35 0.4× 16 0.2× 30 0.4× 28 566
Shunhe Wang China 15 25 0.1× 385 1.8× 72 0.8× 12 0.1× 29 0.4× 31 762
Yavuz Taga Türkiye 11 28 0.1× 241 1.1× 44 0.5× 16 0.2× 36 0.5× 17 704
Bahia Djerdjouri Algeria 18 30 0.1× 359 1.7× 54 0.6× 26 0.3× 7 0.1× 37 792

Countries citing papers authored by H. Zeitler

Since Specialization
Citations

This map shows the geographic impact of H. Zeitler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Zeitler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Zeitler more than expected).

Fields of papers citing papers by H. Zeitler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Zeitler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Zeitler. The network helps show where H. Zeitler may publish in the future.

Co-authorship network of co-authors of H. Zeitler

This figure shows the co-authorship network connecting the top 25 collaborators of H. Zeitler. A scholar is included among the top collaborators of H. Zeitler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Zeitler. H. Zeitler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malter, Michael P., C. Frisch, H. Zeitler, et al.. (2015). Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies. Seizure. 30. 57–63. 74 indexed citations
2.
Goldmann, Georg, et al.. (2015). Treatment of minor severe acquired haemophilia. Is there a rationale for immunoadsorption?. Atherosclerosis Supplements. 18. 74–79. 4 indexed citations
3.
Ivaškevičius, Vytautas, Georg Goldmann, Cornelia Klein, et al.. (2014). Drei Patienten mit milder Hämophilie A der Variante T295A. Hämostaseologie. 34. 2 indexed citations
4.
Strassburg, Christian P., et al.. (2014). Long-term outcome of liver transplantation in HCV/HIV coinfected haemophilia patients. Hämostaseologie. 35(2). 175–180. 2 indexed citations
5.
Klein, Cornelia, T. Albert, H. Zeitler, et al.. (2014). Inhibitor development and management in three non-severe haemophilia A patients with T295A variant. Hämostaseologie. 34(S 01). S9–S12. 2 indexed citations
6.
Zeitler, H., et al.. (2013). Long term outcome of patients with acquired haemophilia – A monocentre interim analysis of 82 patients. Atherosclerosis Supplements. 14(1). 223–228. 21 indexed citations
7.
Ulrich‐Merzenich, G, O Kelber, Axel Freischmidt, et al.. (2012). Novel neurological and immunological targets for salicylate-based phytopharmaceuticals and for the anti-depressant imipramine. Phytomedicine. 19(10). 930–939. 19 indexed citations
8.
Ulrich‐Merzenich, G, O Kelber, Axel Freischmidt, et al.. (2011). Prediction of adverse events by in vivo gene expression profiling exemplified for phytopharmaceuticals containing salicylates and the antidepressant imipramine. Phytomedicine. 19(3-4). 322–329. 7 indexed citations
9.
Pavlova, A., et al.. (2010). HLA genotype in patients with acquired haemophilia A. Haemophilia. 16(102). 107–112. 29 indexed citations
10.
Oldenburg, Johannes, H. Zeitler, & A. Pavlova. (2010). Genetic markers in acquired haemophilia. Haemophilia. 16(s3). 41–45. 40 indexed citations
11.
Ulrich‐Merzenich, G, Darius Panek, H. Zeitler, H. Vetter, & Hildebert Wagner. (2010). Drug development from natural products: exploiting synergistic effects.. PubMed. 48(3). 208–19. 95 indexed citations
12.
Ulrich‐Merzenich, G, Darius Panek, H. Zeitler, Hildebert Wagner, & H. Vetter. (2009). New perspectives for synergy research with the “omic”-technologies. Phytomedicine. 16(6-7). 495–508. 77 indexed citations
13.
Zeitler, H., G Ulrich‐Merzenich, Georg Goldmann, et al.. (2008). The relevance of the bleeding severity in the treatment of acquired haemophilia – an update of a single‐centre experience with 67 patients. Haemophilia. 16(102). 95–101. 35 indexed citations
14.
15.
Pavlova, A., Amalia Díaz‐Lacava, H. Zeitler, et al.. (2007). Increased frequency of the CTLA‐4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls. Haemophilia. 14(2). 355–360. 29 indexed citations
16.
Ulrich‐Merzenich, G, et al.. (2006). Application of the “-Omic-” technologies in phytomedicine. Phytomedicine. 14(1). 70–82. 123 indexed citations
17.
Zeitler, H., G Ulrich‐Merzenich, Peter Walger, et al.. (2006). Das modifizierte Bonn-Malmö-Protokoll in der Behandlung der erworbenen Hemmkörperhämophilie. DMW - Deutsche Medizinische Wochenschrift. 131(4). 141–147. 11 indexed citations
18.
Zeitler, H., et al.. (1997). Cell-cycle arrest in G0/G1 phase of growth factor-induced endothelial cell proliferation by various calcium channel blockers.. PubMed. 21(4). 332–9. 16 indexed citations
19.
Mysliwietz, Josef, et al.. (1993). Biotin labeling as an alternative nonradioactive approach to determination of red cell survival. Annals of Hematology. 67(2). 81–87. 52 indexed citations
20.
Hoffmann‐Fezer, G., et al.. (1991). Direct in vivo biotinylation of erythrocytes as an assay for red cell survival studies. Annals of Hematology. 63(4). 214–217. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu Guan Breakdown of academic impact, for papers by Masayoshi Kibata Breakdown of academic impact, for papers by Valeriu Atanasiu Breakdown of academic impact, for papers by Darius Panek Breakdown of academic impact, for papers by Hans Dierck Waller Breakdown of academic impact, for papers by Hasan Veysi Güneş Breakdown of academic impact, for papers by Yifang Li Breakdown of academic impact, for papers by Shunhe Wang Breakdown of academic impact, for papers by Yavuz Taga Breakdown of academic impact, for papers by Bahia Djerdjouri
Rankless by CCL
2026